Cyclerion Therapeutics earnings were -$3.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CYCN earnings report on Dec 31, 2024 announced Q4 2024 earnings of $530.0k, down 173.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CYCN reported annual earnings of -$3.1M, with -41.9% growth. The next CYCN earnings date is May 5, 2025.
Cyclerion Therapeutics Earnings Reports & History FAQ
What were Cyclerion Therapeutics's earnings last quarter?
On CYCN's earnings call on Invalid Date, Cyclerion Therapeutics (NASDAQ: CYCN) reported Q4 2024 earnings per share (EPS) of $0.22, up 131.43% year over year. Total CYCN earnings for the quarter were $530.00 thousand. In the same quarter last year, Cyclerion Therapeutics's earnings per share (EPS) was -$0.70.
The next CYCN earnings date is Invalid Date. Add CYCN to your watchlist to be reminded of Cyclerion Therapeutics's next earnings date.
What was CYCN's earnings growth in the past year?
As of Cyclerion Therapeutics's earnings date in Invalid Date, Cyclerion Therapeutics's earnings has grown year over year. CYCN earnings in the past year totalled -$3.06 million.
Is Cyclerion Therapeutics profitable or losing money?
As of the last Cyclerion Therapeutics earnings report, Cyclerion Therapeutics is currently losing money. Cyclerion Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$3.06 million, a 41.92% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.